We are monitoring the impact of COVID-19 on North America Contraceptives Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1155
Share on
Share on

North America Contraceptives Market Research Report – Segmented By Drug Type, Medical Devices, End-Users, Country (the United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2021 to 2026

Pulished: April, 2021
ID: 1155
Pages: 136

North America Contraceptives Market Size (2021 to 2026)

As per our report, the Contraceptives Market size in North America was worth USD 7.80 billion in 2021 and estimated to reach USD 10.64 billion by the end of 2026, registering a CAGR of 6.40% during the forecast period.

Contraception methods can be permanent or temporary that are available for both men and women. Permanent methods include tubal occlusion or hysteroscopy and vasectomy. Temporary methods are of two types, i.e., hormonal and non-hormonal, in which hormonal methods include contraceptive transdermal patches, hormonal IUDs, oral contraceptive pills, vaginal implants, and vaginal rings. Non-hormonal methods include diaphragms, withdrawal methods, sponges, condoms, non-hormonal IUDs, and cervical caps. Condoms, sponges, diaphragms, and cervical caps are also referred to as barrier contraception methods.

Awareness regarding family planning and applying the one-child policy in North American nations will boost the market. Government initiative & promotion over contraceptives to control the birth rate and avoid unwanted pregnancies are estimated to support market growth. Less cost consistent and timely use of effective contraceptives in youth is projected to favor the North American contraceptive market. 

Lack of knowledge over the use of the products is a significant factor hindering the market demand. Rising complication issues are also limiting the need of the market. Intake of particular contraceptives may cause breast cancer and other diseases, impeding the market demand. The availability of alternative products is also hampering the growth rate of the contraceptive market. 

This research report on the North American Contraceptives Market has been segmented & sub-segmented into the following categories:

By Drug Type: 

  • Contraceptive Pills
  • Topical Contraceptives
  • Contraceptive Injectable
  • Others (Contraceptive Gels, Jellies, and Creams)

By Medical Devices: 

  • Male Contraceptive Devices (Condoms)
  • Female Contraceptive Devices
    • Female Condoms
    • Intrauterine Devices
      • Hormonal IUD’s
      • Copper IUD’s
  • Contraceptive Sponges
  • Contraceptive Diaphragms
  • Subdermal Contraceptive Implants
  • Contraceptive Patches
  • Non-Surgical Permanent Contraceptive Devices

By End User: 

  • Hospitals
  • Home Care
  • Clinics
  • Ambulatory Surgical Centres

By Country: 

  • The U.S.
  • Canada
  • Rest of North America

Geographically, North America has the highest rate of male sterilization in the world, around 11.9%. Canadian institutes & NGOs arranged counseling programs to create awareness. The U.S. contraceptives market to play the leading role in the North American market. The World Health Organization says, in developing countries, 214 million women are using contraceptive pills to avoid pregnancy in the United States. It is a significant factor for the market to grow in the United States. Increasing support from government organizations is one of the factors propelling the growth rate of the market.  

The Canadian contraceptives market is leading, with prominent shares following the United States. The increasing population and growing awareness of contraceptive pills are majorly driving the demand of the market. Mexico is expected to have significant growth opportunities in the coming years with the increasing number of hospitals and pharmaceuticals.   

Some of the key players that are dominating the North America contraceptives market are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Drug type                              

                                5.1.1 Contraceptive pills               

                                5.1.2 Topical contraceptives       

                                5.1.3 Contraceptive injectable   

                                5.1.4 Others (contraceptive gels, jellies and creams)        

                5.2 By Medical Devices                 

                                5.2.1 Male contraceptive devices             

                                5.2.2 Female contraceptive devices        

                                                5.2.2.1 Female condoms

                                                5.2.2.2 Intrauterine devices

                                                5.2.2.3 Contraceptive sponges

                                                5.2.2.4 Contraceptive diaphragms

                                                5.2.2.5 Contraceptive patches

                                                5.2.2.6 Subdermal contraceptive implants

                                                5.2.2.7 Non-surgical permanent contraceptive devices

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 United States            

                                6.3 Canada         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bayer HealthCare AG                             

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Teva Pharmaceutical Industries Limited                         

                8.3 Medisafe Distribution Inc                     

                8.4 Pace Pharmaceuticals Inc                     

                8.5 Medicines360                            

                8.6 Church & Dwight, Co., Inc.                   

                8.7 Actavis, Inc                 

                8.8 CooperSurgical                         

                8.9 Merck & Co., Inc                       

                8.10 Reckitt Benckiser plc                            

                8.11 Mayer Laboratories, Inc                      

                8.12 Pfizer, Inc                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Market outlook and Investment oppurtunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Contraceptives Market By Drug type, From 2021 to 2026 (USD Million)
  2. North America Contraceptive pills Market By Region, From 2021 to 2026 (USD Million)
  3. North America Topical contraceptives Market By Region, From 2021 to 2026 (USD Million)
  4. North America Contraceptive injectable Market By Region, From 2021 to 2026 (USD Million)
  5. North America Contraceptives Market By Medical Devices, From 2021 to 2026 (USD Million)
  6. North America Male Contraceptive devices Market By Region, From 2021 to 2026 (USD Million)
  7. North America Female Contraceptive devices Market By Region, From 2021 to 2026 (USD Million)
  8. North America Contraceptives Market By End users, From 2021 to 2026 (USD Million)
  9. North America Hospitals Market By Region, From 2021 to 2026 (USD Million)
  10. North America Home care Market By Region, From 2021 to 2026 (USD Million)
  11. North America Clinics Market By Region, From 2021 to 2026 (USD Million)
  12. North America Ambulatory Surgical Centres Market By Region, From 2021 to 2026 (USD Million)
  13. United States Contraceptives Market By Drug type, From 2021 to 2026 (USD Million)
  14. United States Contraceptives Market By Medical Devices, From 2021 to 2026 (USD Million)
  15. United States Contraceptives Market By End users, From 2021 to 2026 (USD Million)
  16. Canada Contraceptives Market By Drug type, From 2021 to 2026 (USD Million)
  17. Canada Contraceptives Market By Medical Devices, From 2021 to 2026 (USD Million)
  18. Canada Contraceptives Market By End users, From 2021 to 2026 (USD Million)
  19. North America Contraceptives Market Market By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  20. North America female condoms Market By Region, From 2021 to 2026 (USD Million)
  21. North America intrauterine devices Market By Region, From 2021 to 2026 (USD Million)
  22. North America contraceptive sponges Market By Region, From 2021 to 2026 (USD Million)
  23. North America contraceptive diaphragms Market By Region, From 2021 to 2026 (USD Million)
  24. North America contraceptive patches Market By Region, From 2021 to 2026 (USD Million)
  25. North America subdermal contraceptive implants Market By Region, From 2021 to 2026 (USD Million)
  26. North America non-surgical permanent contraceptive devices Market By Region, From 2021 to 2026 (USD Million)
  27. United States Contraceptives Market Market By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  28. Canada Contraceptives Market Market By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  29. North America Contraceptives Market Market By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  30. North America female condoms Market By Region, From 2021 to 2026 (USD Million)
  31. North America intrauterine devices Market By Region, From 2021 to 2026 (USD Million)
  32. North America contraceptive sponges Market By Region, From 2021 to 2026 (USD Million)
  33. North America contraceptive diaphragms Market By Region, From 2021 to 2026 (USD Million)
  34. North America contraceptive patches Market By Region, From 2021 to 2026 (USD Million)
  35. North America subdermal contraceptive implants Market By Region, From 2021 to 2026 (USD Million)
  36. North America non-surgical permanent contraceptive devices Market By Region, From 2021 to 2026 (USD Million)
  37. United States Contraceptives Market Market By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  38. Canada Contraceptives Market Market By Female contraceptive Devices, From 2021 to 2026 (USD Million)
  39. North America Contraceptives Market Market By Intrauterine devices, From 2021 to 2026 (USD Million)
  40. North America Hormonal IUD's Market By Region, From 2021 to 2026 (USD Million)
  41. United States Contraceptives Market Market By Intrauterine devices, From 2021 to 2026 (USD Million)
  42. Canada Contraceptives Market Market By Intrauterine devices, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample